Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Archives of Osteoporosis|April 18, 2022
Physical activity estimated by osteogenic potential and energy expenditure has differing associations with bone mass in young adults: the raine studyCarrie-Anne Ng, David Scott, Marc Sim, et al.Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|January 11, 2021
The Effect of Radium-223 Therapy in Agent Orange-Related Prostate CarcinomaAndrew Liman, Rashmikant Shah, Vida Passero, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 16, 2023
Reduced Peak Bone Mass in Young Adults With Low Motor CompetenceJocelyn Tan, Carrie-Anne Ng, Nicolas H Hart, et al.Multiple Sclerosis and Related Disorders|June 24, 2025
Design, acceptability, and measured outcomes of music interventions for walking in persons with multiple sclerosis: A scoping reviewJocelyn Tan, Ann Maree Vallence, Hannah Fenwick, et al.Parkinsonism & Related Disorders|June 27, 2022
Biofluid markers of blood-brain barrier disruption and neurodegeneration in Lewy body spectrum diseases: A systematic review and meta-analysisYuen Yan Wong, Che-Yuan Wu, Di Yu, et al.Journal of Medicinal Chemistry|June 24, 2010
Spirotetrahydro beta-carbolines (spiroindolones): a new class of potent and orally efficacious compounds for the treatment of malariaBryan K S Yeung, Bin Zou, Matthias Rottmann, et al.Bone Marrow Transplantation|April 29, 2021
The association of mobilising regimen on immune reconstitution and survival in myeloma patients treated with bortezomib, cyclophosphamide and dexamethasone induction followed by a melphalan autograftMatthew J Rees, Peter Mollee, Jun Yen Ng, et al.Science (New York, N.Y.)|September 4, 2010
Spiroindolones, a potent compound class for the treatment of malariaMatthias Rottmann, Case McNamara, Bryan K S Yeung, et al.ACS Medicinal Chemistry Letters|August 23, 2014
Lead optimization of imidazopyrazines: a new class of antimalarial with activity on Plasmodium liver stagesBin Zou, Advait Nagle, Arnab K Chatterjee, et al.BMC Medicine|December 5, 2024
Clinical research framework proposal for ketogenic metabolic therapy in glioblastomaTomás Duraj, Miriam Kalamian, Giulio Zuccoli, et al.Pageof 2